Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Slamon DJ, Clark GM, Wong SG et al (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182
2. Press MF, Pike MC, Chazin VR et al (1993) Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Cancer Res 53:4960–4970
3. Tandon AK, Clark GM, Chamness GC et al (1989) HER-2/neu oncogene protein and prognosis in breast cancer. J Clin Oncol 7:1120–1128
4. Lal P, Salazar PA, Hudis CA et al (2004) HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization: a single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring. Am J Clin Pathol 121:631–636
5. Park JW, Neve RM, Szollosi J et al (2008) Unraveling the biologic and clinical complexities of HER2. Clin Breast Cancer 8:392–401